CRYOPORT, INC. Goodwill, Foreign Currency Translation Gain (Loss)
CRYOPORT, INC. (CYRX) reported Goodwill, Foreign Currency Translation Gain (Loss) of -$332.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:GoodwillForeignCurrencyTranslationGainLoss · last filed 2026-08-06
- CRYOPORT, INC. goodwill, foreign currency translation gain (loss) for the quarter ending 2026-06-30 was -$69.00K.
- CRYOPORT, INC. goodwill, foreign currency translation gain (loss) for the quarter ending 2026-03-31 was -$263.00K, a 167.26% decline year-over-year.
- CRYOPORT, INC. goodwill, foreign currency translation gain (loss) for the quarter ending 2025-12-31 was -$9.00K.
- CRYOPORT, INC. goodwill, foreign currency translation gain (loss) for the quarter ending 2025-09-30 was $3.70M, a 151.09% increase year-over-year.
- CRYOPORT, INC. goodwill, foreign currency translation gain (loss) for fiscal 2024 was -$1.26M.
- CRYOPORT, INC. goodwill, foreign currency translation gain (loss) for fiscal 2023 was -$284.00K.
- CRYOPORT, INC. goodwill, foreign currency translation gain (loss) for fiscal 2022 was -$5.39M.
- CRYOPORT, INC. goodwill, foreign currency translation gain (loss) for fiscal 2021 was -$419.00K.
| Period end | Goodwill, Foreign Currency Translation Gain (Loss) 3 month | Goodwill, Foreign Currency Translation Gain (Loss) 6 month | Goodwill, Foreign Currency Translation Gain (Loss) 9 month | Goodwill, Foreign Currency Translation Gain (Loss) 9 month as first filed | Goodwill, Foreign Currency Translation Gain (Loss) 12 month | Goodwill, Foreign Currency Translation Gain (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$69.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$332.00K 10-Q · filed 2026-08-06 | -$341.00K derived: sum of 3 quarters · filed 2026-08-06 | $3.35M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | -$263.00K 10-Q · filed 2026-05-05 | -$272.00K derived: sum of 2 quarters · filed 2026-08-06 | $3.42M derived: sum of 3 quarters · filed 2026-08-06 | $1.18M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | -$9.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2026-08-06 | $3.69M derived: sum of 2 quarters · filed 2026-08-06 | $1.44M derived: sum of 3 quarters · filed 2026-08-06 | $1.83M 10-Q · filed 2026-08-06 | ||
| 2025-09-30 | $3.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.45M derived: sum of 2 quarters · filed 2025-11-06 | $1.84M 10-Q · filed 2025-11-06 | $567.00K derived: sum of 4 quarters · filed 2026-03-05 | ||
| 2025-06-30 | -$2.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$1.86M 10-Q · filed 2025-08-12 | -$3.13M derived: sum of 3 quarters · filed 2026-03-05 | -$1.66M derived: sum of 4 quarters · filed 2026-03-05 | ||
| 2025-03-31 | $391.00K 10-Q · filed 2025-05-08 | -$882.00K derived: sum of 2 quarters · filed 2026-03-05 | $590.00K derived: sum of 3 quarters · filed 2026-03-05 | -$51.00K derived: sum of 4 quarters · filed 2026-03-05 | ||
| 2024-12-31 | -$1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $199.00K derived: sum of 2 quarters · filed 2026-03-05 | -$442.00K derived: sum of 3 quarters · filed 2026-03-05 | -$1.26M 10-K · filed 2026-03-05 | -$2.38M 10-K · filed 2025-03-07 | |
| 2024-09-30 | $1.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $831.00K derived: sum of 2 quarters · filed 2024-11-07 | $16.00K 10-Q · filed 2024-11-07 | $1.90M derived: sum of 4 quarters · filed 2025-03-07 | ||
| 2024-06-30 | -$641.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$1.46M 10-Q · filed 2024-08-08 | $430.00K derived: sum of 3 quarters · filed 2025-03-07 | $69.00K derived: sum of 4 quarters · filed 2025-03-07 | ||
| 2024-03-31 | -$815.00K 10-Q · filed 2024-05-08 | $1.07M derived: sum of 2 quarters · filed 2025-03-07 | $710.00K derived: sum of 3 quarters · filed 2025-03-07 | -$1.60M derived: sum of 4 quarters · filed 2025-03-07 | ||
| 2023-12-31 | $1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $1.52M derived: sum of 2 quarters · filed 2025-03-07 | -$783.00K derived: sum of 3 quarters · filed 2025-03-07 | -$284.00K 10-K · filed 2025-03-07 | ||
| 2023-09-30 | -$361.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$2.67M derived: sum of 2 quarters · filed 2023-11-09 | -$2.17M 10-Q · filed 2023-11-09 | -$2.17M derived: sum of 4 quarters · filed 2024-03-13 | ||
| 2023-06-30 | -$2.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$1.81M 10-Q · filed 2023-08-09 | -$1.81M derived: sum of 3 quarters · filed 2024-03-13 | -$2.83M derived: sum of 4 quarters · filed 2024-03-13 | ||
| 2023-03-31 | $499.00K 10-Q · filed 2023-05-04 | $499.00K derived: sum of 2 quarters · filed 2024-03-13 | -$523.00K derived: sum of 3 quarters · filed 2024-03-13 | -$4.52M derived: sum of 4 quarters · filed 2024-03-13 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | -$1.02M derived: sum of 2 quarters · filed 2024-03-13 | -$5.02M derived: sum of 3 quarters · filed 2024-03-13 | -$5.39M 10-K · filed 2024-03-13 | ||
| 2022-09-30 | -$1.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$5.02M derived: sum of 2 quarters · filed 2023-11-09 | -$5.39M 10-Q · filed 2023-11-09 | -$8.16M 10-Q · filed 2022-11-04 | -$4.72M derived: sum of 4 quarters · filed 2023-11-09 | |
| 2022-06-30 | -$4.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$4.37M 10-Q · filed 2023-08-09 | -$3.69M derived: sum of 3 quarters · filed 2023-08-09 | -$4.30M derived: sum of 4 quarters · filed 2023-08-09 | ||
| 2022-03-31 | -$369.00K 10-Q · filed 2023-05-04 | $305.00K derived: sum of 2 quarters · filed 2023-05-04 | -$305.00K derived: sum of 3 quarters · filed 2023-05-04 | $617.00K derived: sum of 4 quarters · filed 2023-05-04 | ||
| 2021-12-31 | $674.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $64.00K derived: sum of 2 quarters · filed 2023-02-28 | $986.00K derived: sum of 3 quarters · filed 2023-02-28 | -$419.00K 10-K · filed 2023-02-28 | ||
| 2021-09-30 | -$610.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $312.00K derived: sum of 2 quarters · filed 2022-11-04 | -$1.09M 10-Q · filed 2022-11-04 | |||
| 2021-06-30 | $922.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$483.00K 10-Q · filed 2022-08-04 | ||||
| 2021-03-31 | -$1.41M 10-Q · filed 2022-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |